FULL POSTER SESSION ABSTRACTSSignaling pathways are important in coordinating fungal cellular processes required for stress resistance, development and pathogenicity. The Mps1 MAPkinase pathway of Magnaporthe oryzae is involved in cell wall integrity, sporulation and pathogenicity. Dmps1 mutants displayed an abnormal mycelialgrowth (reduced aerial hyphae and melanisation), did not sporulate and were non-pathogenic on plants as reported (a). Sensitivity of M. oryzae to cell walldegrading enzymes (CWDE) and cell wall inhibitors (CWI) was found to be dependent on pH. Indeed, M. oryzae cell walls display a resistance to enzymaticdegradation at pH 5, while they are sensitive at pH 6. Dmps1 loses this pH 5 induced cell wall resistance, while it is as sensitive to CWDE as wild type at pH6. M. oryzae is highly resistant to calcofluor (cell wall disorganizing agent) at pH 5 (10x) compared to pH 6. Dmps1 loses this pH 5 induced calcofluorresistance, while it is as sensitive as wild type at pH 6. M. oryzae is more sensitive (20x) to Nikkomycin Z (chitine synthase inhibitor) at pH 5 than pH 6,while sensitivity to Aculeacin (glucan synthase inhibitor) is independent of the pH. However, Dmps1 is as sensitive as wild type to these inhibitors at bothpH. We conclude that the pH 5 induced resistance of fungal cell walls to CWDE and calcofluor requires the Mps1 pathway. This also suggests that the Mps1pathway is strongly activated at pH 5 compared to pH 6. To test this hypothesis, we are assaying the phosphorylation status of Mps1 at different pH as wellas under several stress conditions and developmental stages to know when this pathway is activated. Additionally we constructed an activated allele ofMkk1, the MAPKK upstream of Mps1, placed under the control of either its own promoter (b) or the repressible pNIA1 promoter. These transformants willbe used to assess the effect of controlled activation of the Mps1 pathway on M. oryzae cellular functions. The different conditions of Mps1 pathwayactivation will be used for a comparative transcriptomic analysis of wild type and Dmps1 mutants.(a) Xu, 2000. <strong>Fungal</strong> Genet. Biol. 31:137-152.(b) Fujikawa et al., 2009. Mol. Microbiol. 73(4):553-70.241. A RNA-Seq directed functional genomics screen to identify novel cell wall genes in the hyphal tip of Neurospora crassa. Divya Sain, Lorena Rivera,Jason Stajich. Plant Pathology & Microbiology, University of California, Riverside, Riverside, CA.The cell wall is one of the most important organelles of the fungal cell and differentiates pathogenic fungi from the plants and animals they infect. Thismakes cell wall biosynthesis an excellent target for anti-fungal drugs. To identify new targets we employed a functional genomics approach informed bygene expression patterns based on RNA-Seq of the filamentous fungus Neurospora crassa. The growing tips of fungal hyphae are enriched for cell wallbiosynthesis activity proteins and transcripts (1-2). Based on this idea we sequenced RNA from the tip (1 hr growth) and colony interior (20 hr growth) ofvegetative growing culture of N. crassa. 70 genes were up-regulated in the tip (at least 5 fold) and we supplemented this list with 42 tip expressed genesfrom a study of N. crassa colony development using microarrays, where mRNA transcripts in the colony tips were enriched in functional categories relatedto cell wall growth and morphogenesis (2). We used the N. crassa knockout collection (3) to identify developmental phenotypes and under chemical stressconditions to expose sensitivity in cell wall and growth defects. Almost 60 percent of the genes were found to be sensitive to cell wall stress agents,Caspofungin (cell wall integrity inhibition) and SDS (cell wall disruption) suggesting that our gene-set was enriched for genes having a cell wall defect. Wetested these genes for defects in the hyper-osmolar stress (NaCl & Glycerol) and oxidative stress pathways as well as sexual development pathway. Wefound 20 knockout strains having defects in all or nearly all of these pathways suggesting these cell wall genes are involved in multiple pathways of growthand development of filamentous fungi. This set includes Zn-Cys transcription factors (NCU04866 & NCU04663), Glycoside Hydrolase 13 family proteins(NCU08131 & NCU08132) and genes with no annotated function (NCU04826 & NCU01254). All of these genes possess homologs in other Peziomycotinafungi. Hence our approach using gene expression selected a candidate gene-set enriched for growth processes that may be useful as targets for anti-fungaldrug development against filamentous pathogenic fungi. 1) Bartnicki-Garcia & Lippman. Science 1969; 165(3890):302-4. 2) Kasuga & Glass. Euk Cell 2008;7(9):1549-64. 3) Colot et al. PNAS 2006; 103(27):10352-7.242. Identification of centromeres in the plant pathogen Zymoseptoria tritici (synonym Mycosphaerella graminicola). Klaas Schotanus 1 , Lanelle R.Connolly 2 , Kristina M. Smith 2 , Michael Freitag 2 , Eva H. Stukenbrock 1 . 1) MPRG <strong>Fungal</strong> Biodiversity, Max-Planck-Institute for Terrestrial Microbiology,Marburg, Germany; 2) Department of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, USA.Several plant pathogenic fungi contain small, apparently dispensable chromosomes, and in several cases pathogenicity genes have been identified onthese chromosomes. The ascomycete Zymoseptoria tritici has up to eight dispensable chromosomes in addition to thirteen “core” chromosomes. Duringmeiosis dispensable chromosomes are lost at elevated rates, resulting in progeny with distinct novel chromosome sets. So far little is known about the roleof these chromosomes and their evolutionary dynamics. We hypothesize that loss of dispensable chromosomes during meiosis may be correlated tounstable centromeres. Thus, one goal was to identify and characterize centromeric regions on core and dispensable chromosomes to allow us toinvestigate the underlying genetics of chromosome instability. Both core and dispensable chromosomes in the Z. tritici reference isolate IPO323 have beensequenced from telomere to telomere, yielding a unique opportunity to identify the centromeric regions in the genome. We tagged the Z. triticicentromere-specific histone 3 (CenH3) with GFP and confirmed correct insertion by Southern analyses. We demonstrate expression of GFP-tagged CenH3by western blot and epifluorescence microscopy. ZtCenH3-GFP was localized in discrete foci in interphase nuclei, but in contrast to other fungi (e.g.,Neurospora, Fusarium, Saccharomyces and Schizosaccharomyces) there are several foci per nucleus instead of a single chromocenter. We also performedchromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) on the CenH3-GFP strains. To confirm the CenH3-GFP results, we tagged twoadditional centromere proteins (CEN-B and CEN-S) with GFP. To assess stability of centromeres during mitosis and meiosis, we obtained evolved asexualprogeny of IPO323 after 50 and 100 generations and progeny from a cross. Comparison of centromeric positions in the genome of the founder strain(IPO323) versus sexual and asexual progeny will allow us to infer dynamics of centromeres on core and dispensable chromosomes, and aid in ourunderstanding of the evolutionary dynamics of dispensable chromosomes in fungal plant pathogens.243. Loss of the RNAi pathway in VGII Cryptococcus gattii sheds light on the intact system in Cryptococcus neoformans. R Blake Billmyre, Xuying Wang,Marianna Feretzaki, Joseph Heitman. Duke University, Durham, NC.Loss of RNAi in VGII Cryptococcus gattii sheds light on RNAi roles in Cryptococcus neoformans R. Blake Billmyre, Xuying Wang, Marianna Feretzaki, andJoseph Heitman RNAi is a broadly conserved homology-dependent silencing mechanism which functions to defend the genome by silencing transposonsand viral elements. The opportunistic human pathogen C. neoformans, utilizes an RNAi-dependent process to robustly silence repetitive elements duringthe sexual cycle. Interestingly, RNAi components have been broadly lost from the VGII subtype of the closely related sister species C. gattii. We have takena comparative genomics approach to compare the RNAi deficient genome of VGII C. gattii with the RNAi proficient genomes of VGI C. gattii and serotypesA and D C. neoformans. This approach has identified a total of fourteen gene losses or truncations of otherwise conserved genes in VGII, including three ofthe known canonical RNAi components. Two of the remaining eleven genes have been shown to have a role in the sex-induced silencing pathway in C.neoformans var. grubii, despite a lack of homology with previously identified RNAi components in other organisms. One of these genes CPR2, waspreviously studied in our lab as a constitutively active G-protein coupled pheromone receptor. cpr2D also confers a moderate defect in sex-inducedsilencing, but no defect in silencing during vegetative growth. Similarly, the zinc finger factor Znf3 was previously identified in our lab and here was180
FULL POSTER SESSION ABSTRACTSunexpectedly found to be important for both sex-induced and vegetative silencing. The nine remaining missing genes are being tested for roles in bothsex-induced and mitotic silencing (SIS, MIS).244. A chemical-genetic map of a human fungal meningitis pathogen. Jessica C. S. Brown 1 , Benjamin VanderSluis 2 , Raamesh Deshpande 2 , Arielle Butts 3 ,Sarah Kagan 4 , Itzhack Polacheck 4 , Damian J. Krysan 3 , Chad L. Myers 2 , Hiten D. Madhani 1 . 1) Biochemistry and Biophysics, U. California, San Francisco, SanFrancisco, CA; 2) Computer Science and Engineering, U. Minnesota, Minneapolis, MN; 3) Pediatrics, U. Rochester Medical Center, Rochester, NY; 4) ClinicalMicrobiology and Immunology, Tel Aviv University, Tel Aviv, Israel.The systematic profiling of the impact of small molecules on the growth rate of gene deletion mutants is termed chemogenomic profiling. This approachbeen extensively used in model organisms, primarily baker’s yeast, to functionally annotate genes and to obtain insights into mode-of-action (MOA) forchemical compounds (1). Here we describe the application of systematic chemical-genetics a significant human pathogen. Cryptococcus neoformans is anopportunistic basidiomycetes pathogen responsible for lethal meningitis in immunocompromised patients. Current therapies are inadequate due to apaucity of drugs and a poor understanding of pathogenesis. Our laboratory previously constructed a partial gene deletion collection and used it to identifynumerous genes required for infection as well as for the production of virulence factors (2). This work identified numerous novel infectivity genes, butmany did not have an identifiable molecular function. We have now used chemogenomic profiling to both bridge this gap in gene annotation and to obtaininsights into drug MOA. To accomplish this goal, we identified and utilized over 200 diverse chemical compounds that impact pathogen growth to create aunique phenotypic signature for ~1500 C. neoformans gene deletion strains. We used colony arrays, robotics, automated image analysis, and extensivedata normalization algorithms to analyze several million phenotypic measurements. We used these data to identify clusters of genes and compounds withrelated patterns of chemical-genetic interactions. Our analysis identified virulence genes that act through related mechanisms. For example, one gene setinvolves a number predicted to be involved in histone modification. Members of a second set of genes are required in production of the C. neoformanspolysaccharide capsule, a well-established virulence factor. We have also obtained new insights into the MOA of several antifungal compounds. TheCryptococcus chemical-genetic map will be a valuable resource for functional annotation of the genome of this meningitis pathogen, characterization ofnew drug targets, and the identification lead compounds for antifungal drug development.1. Hillenmeyer et al., Science 320 (2008). 2. Liu et al., Cell 135 (2008).245. Whole genome sequencing of high-mortality and low-mortality strains of Cryptococcus neoformans var. grubii to discover genetic determinants ofvirulence. Tami R. McDonald, Kirsten Nielsen. Department of Microbiology, University of Minnesota, Minneapolis, MN.In sub-Saharan Africa, meningitis caused by the fungus Cryptococcus neoformans var. grubii is a major cause of AIDS-related mortality. To investigate therole of fungal genotype in clinical disease, we sequenced 8 genes for 503 clinical isolates of Cryptococcus neoformans var. grubii. A phylogenetic analysis ofthese strains demonstrated that 501 isolates were VNI strains. Haplotype network analysis revealed three major groups (BURST groups 1 - 3). Patientmortality was associated with fungal strain genotype, with strains in BURST group 3 demonstrating low mortality. Whole genome sequencing of 13representative genotypes revealed SNPs unique to the high mortality strains, and SNPs unique to the low-mortality strains, pointing to possible targets forfuture gene deletion and allele swap experiments to determine the role of the genes in pathogenesis.246. Identification of high temperature-regulated genes controlled by Sch9 through comparative transcriptome analysis in Cryptococcus neoformans.Dong-Hoon Yang 1 , Kwang-Woo Jung 1 , Jang-Won Lee 1 , Min-Hee Song 1 , Anna Floyd 2 , Joseph Heitman 2,3 , Yong-Sun Bahn 1 . 1) Biotechnology Dept, YonseiUniversity, Seoul, South Korea; 2) Departments of Molecular <strong>Genetics</strong> and Microbiology, Duke University Medical Center, Durham, NC, USA; 3)Departments of Medicine, and Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.Adaptation to temperature changes is one of crucial virulence factors for Cryptococcus neoformans during host infection. In the human fungal pathogen,diverse signal transduction pathways, such as Ras/Cdc24, calmodulin/calcineurin, Mpk1 and Hog1 MAPK pathways, are involved in the temperatureadaptation process. In addition to the pathways, the Sch9 protein kinase has been implicated in thermotolerence of C. neoformans, but its regulatorymechanism remains elusive. In this study we aimed to identify Sch9-dependent or -independent temperature-regulated genes in a genome scale and toelucidate the regulatory mechanism of Sch9 in thermotolerance of C. neoformans. For this purpose, we performed comparative transcriptome analysiswith the wild type serotype A H99 strain and sch9D mutant during temperature upshift from 25°C to 37°C or 40°C. The temperature upshift caused a globalscale of remodeling in gene expression profiles (1872 genes, P
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76:
CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78:
CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82:
CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84:
CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88:
CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90:
CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94:
CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96:
CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104:
CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106:
CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108:
LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110:
LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112:
LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114:
LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116:
LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118:
LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120:
LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122:
LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124:
LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126:
LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128:
FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129 and 130:
FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132:
FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134: FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136: FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138: FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140: FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142: FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144: FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146: FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148: FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150: FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152: FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154: FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156: FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158: FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160: FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162: FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164: FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166: FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168: FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170: FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172: FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174: FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176: FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178: FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180: FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182: FULL POSTER SESSION ABSTRACTSmore g
- Page 183: FULL POSTER SESSION ABSTRACTSmolecu
- Page 187 and 188: FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190: FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192: FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194: FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196: FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198: FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200: FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202: FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204: FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206: FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208: FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210: FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212: FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214: FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216: FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218: FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220: FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222: FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224: FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226: FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228: FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230: FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232: FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234: FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236:
FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238:
FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240:
FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242:
FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244:
FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246:
FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248:
FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250:
FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252:
FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254:
FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256:
FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258:
FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260:
FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262:
FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264:
FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266:
FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268:
FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270:
FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272:
FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274:
FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276:
FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278:
FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280:
FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282:
FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284:
FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286:
FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288:
FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290:
FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292:
FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294:
FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296:
FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298:
FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300:
FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302:
FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304:
FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306:
FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308:
KEYWORD LISTABC proteins ..........
- Page 309 and 310:
KEYWORD LISThigh temperature growth
- Page 311 and 312:
AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314:
AUTHOR LISTFrancis, Martin ........
- Page 315 and 316:
AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318:
AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320:
AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322:
AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324:
LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326:
LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328:
LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni